FIELD: biotechnology.
SUBSTANCE: invention relates to a new effective method for the production of a KDR-targeted peptide-phospholipid conjugate, which can be used in therapeutic and diagnostic compositions and, in particular, in the production of echo-contrast preparations.
EFFECT: obtainment of a peptide-phospholipid conjugate.
10 cl, 2 dwg, 1 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CONJUGATES OF PHOSPHOLIPIDS AND DIRECTION VECTOR MOLECULES | 2006 |
|
RU2433137C2 |
| METHOD FOR OBTAINING SUPRAMOLECULAR PLATINUM COMPOUNDS | 2016 |
|
RU2795256C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING DOXORUBICIN AS PART OF PHOSPHOLIPID NANOPARTICLES USING SELECTIVE DNA APTAMER MOLECULES FOR TARGETED TRANSPORT TO TUMOR CELLS | 2021 |
|
RU2794798C1 |
| COMPOSITION OF FOCUSED MICROVESICLES FILLED WITH GAS | 2015 |
|
RU2725808C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING CHLORIN E6 IN PHOSPHOLIPID NANOPARTICLES USING SPECIFIC AND PENETRATING PEPTIDES AS TARGETED MOLECULES FOR TARGETED TRANSPORT | 2020 |
|
RU2747485C1 |
| ANTAGONIST OF LH-RELEASING FACTOR (LHRH), COMPLEX, METHOD OF CHEMICAL CASTRATION AND/OR TREATMENT OF GONADOTROPIN- -DEPENDENT DISORDERS | 1994 |
|
RU2130464C1 |
| METHOD FOR COMMERCIAL PRODUCTION AND PURIFICATION OF HUMAN RECOMBINANT GROWTH HORMONE OF INCLUSION BODIES | 2011 |
|
RU2473556C1 |
| METHOD FOR POLYALKOXYLATING NUCLEIC ACIDS, ALLOWING FOR EXTRACTION AND REUSE OF EXCESS POLYALKOXYLATING REAGENT | 2017 |
|
RU2765027C2 |
| MODULE MOLECULAR CONJUGATE FOR TARGETING GENETIC CONSTRUCTS AND METHOD FOR PREPARING IT | 2012 |
|
RU2529034C2 |
| DIAGNOSTIC COMPOUNDS | 2005 |
|
RU2396272C9 |
